Focal venous catheter, generally known as central line catheter is a thin, long, versatile tube set in a major vein near the heart. It gets to a major vein by means of the internal jugular vein, femoral vein or subclavian vein. These catheters are used for administrating blood products, blood, supplements, fluids, and medicines. Moreover, these catheters are employed for measuring chemotherapy, haemodialysis and central venous pressure for the length of a delayed extend of time.
The global market for central venous catheter accounted for a figure of about US$ 647.9 Million all through 2015 along with is likely to record a CAGR of 5.1% all through the decade 2016–2026.
Market Segmentation: The global market based on the product type is categorised into non-tunnelled and tunnelled catheters. The non-tunnelled catheters category in revenue terms of share lead the worldwide market for central venous catheter during 2015 and is projected to remain dominant all over the conjecture period.
The worldwide market based on the property of the catheter coating is divided into non-antimicrobial coated and antimicrobial catheters. The non-antimicrobial coated catheters in revenue terms of share lead the worldwide market for central venous catheter during 2015 and are projected to remain dominant all over the conjecture period. While the antimicrobial coated catheter product division is predictable to record the highest CAGR throughout the anticipated period.
The global market based on the design is segmented into multi-lumen, double lumen and single lumen catheter. The multi lumen catheters represented the maximum revenue as of the market for central venous catheter.; The global market on the basis of the composition is segmented into silicone, polyurethane/polycarbonate and polyurethane. The polyurethane composition segment will represent the maximum revenue as of the market for central venous catheter.
The overall market on the basis of the end user is categorised into specialized clinics, ambulatory surgical centres and hospitals. The hospitals segment presently represents the maximum revenue as of the market for central venous catheter.
The prominent regions assessed in the overall market include Latin America, North America, Eastern Europe, Western Europe, Japan Asia Pacific Excluding Japan and Middle East & Africa. North America has dominated the worldwide market for central venous catheter during 2015 and will be registering a 4.7% CAGR during 2016-2026. Japan and APEJ are projected as the highest growing regions in revenue terms, whereas Western Europe will be exhibiting a robust CAGR in spite of a drop in population. APEJ will be registering a 6.2% CAGR in value terms during 2016-2026.
Key Market Players: Some of the prominent companies in the global market for central venous catheter are: R. Bard, AngioDynamics, Kimal, Teleflex Incorporated, Vygon (UK) Ltd., Braun Melsungen AG, others
Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-949